Effects of acetylate hyperforin on the processing of amyloid precursor protein

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 1, Issue 1, 2009, Pages 76-82

  Chen, Xiang ^a   Feng, Wenshang ^a   Chen, Qing ^a   Yang, Xiangling ^a   Yang, Depo ^a   Wang, Dongmei ^a   Zhong, Ling ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Alzheimer's disease (AD); Hyperforin; Protein kinase C (PKC); Soluble amyloid precursor protein (sAPP )

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; CALPHOSTIN C; DNA; HYPERFORIN; MESSENGER RNA;

ARTICLE; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION;

EID: 71049152277     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Selkoe DJ: Alzheimer's disease: genotypes, phenotypes, and treatments, Science 1997; 275: 630-631.
2. Strooper BD, Annaert W: Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 2000; 113:1857-1870.
3. Postina R, Schroeder A, Dewachter J, Bohl J, Schmitt U, Kojro E, et al: A disintegrin-metallo proteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 2004; 113:1456-1464.
4. Jin L, Ninomiya H, Roch J, Schubert D, Masliah E, Otero D, et al: Pepteides containing the RERMS sequence of amyloid (beta)/A4 protein precursor bind cell surface and promote neurite extension,. J Neurosci 1994; 14:5461-5470.
5. Bodovitz S, L.Klein W: Cholesterol modulates alpha-secretase cleavage of amyloid precursor. J Biol Chem 1996; 271:4436-4440.
6. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE: Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 1993; 10:243-254.
7. Thornton E, Vink R, Blumbergs PC, Van Den Heuvel C: Soluble amyloid precursor protein α reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res 2006; 1094:38-46.
8. Famer D, Meaney S, Mousavi M, Norberg A, Bjorkhem I, Crisby M: Regulation of α- and β-seccretase activity by oxysterols: cerebrosterol stimulates processing of APP via the α-secretase pathway. Biochem Biophys Res Commun 2007; 359: 46-50.
9. Zanli P: Role of hyperforin in the pharmacological activities of St. John's Wort. CNS Drug Rev 2004; 10:203-218.
10. Whiskey E, Wernecke U, Taylor D: A systermatic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review. Int Clin Psychopharmacol 2001; 16: 239-252.
11. Medina MA, Martinez-Poveda B, Amores-Sanchez MI, Quesada AR: Hyperforin: More than an antidepressant bioactive compound? Life Sci 2006; 79:105-111.
12. Froestl B, Steiner B, Muller WE: Enhancement of proteolytic processing of the beta-amyloid precursor protein by hyperforin. Biochem Pharmacol 2003; 66:2177-2184.
13. Ang CY, Hu L, Heinze TM, Cui Y, Freeman JP, Kozak K, et al: Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage. J Agric Food Chem 2004; 52:6156-6164.
14. Bombardelli E, Morazzoni P, Riva A, Fuzzati N: Hyperforin derivatives, the use there of and formulations containing them. 2003; WO Patent: 2003091194.
15. Liang YH, Wang DM, Yang DP, Guo ZM, Li WM: Advance in chemical and neuropharmacological studies on hyperforin and its derivatives. Chinese Traditional and Herbal Drugs 2007; 38:11-13.
16. Lefterov I., Koldamova RP, Lazo JS: Human bleomycin hydrolase regulates the secretion of a myloid precursor protein. FASEB J 2000; 14:1837-1847.
17. Lanni C, Mazzucchelli M, Porrello E, Govoni S, Racchi M: Differential involvement of protein kinase C alpha and epsilon in the regulated secretion of soluble amyloid precursor protein. Eur J Biochem 2004; 271:3068-3075.
18. Stein TD, Anders NJ, DeCarli C, Chan SL, Mattson MP, Johnson JA: Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPsw mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J Neurosci 2004; 24:7707-7717.
19. Buxbaum JD, Liu KN, Luo Y, Slack JL, Stockin KL, Peschon JJ, et al: Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloidprotein precursor. J Biol Chem 1998; 273:27765-27767.
20. Cedazo-Minguez A, Bonecchi L, Winblad B, Post C, Wong EH, Cowburn RF, Benatti L: Nicergoline stimulates protein kinase C mediated α-secretase processing of the amyloid precursor protein in cultured human neuroblastoma SHSY5Y cells. Neurochem Int 1999; 35:307-315.